Betsy ReznerDirector, Process & Assay Development at Fate Therapeutics Inc.
Betsy Rezner is the Senior Director of Process & Assay Development at Fate Therapeutics located in San Diego, CA. In this role, she oversees process development and analytical method development for Fate’s novel, off-the-shelf engineered iPSC-derived NK cell cancer immunotherapy. Over the past 3 years, Betsy and her team have focused on developing robust, scalable manufacturing processes and analytical tools, thus enabling successful IND applications and initiation of several clinical studies. Previously, she led phenotypic screening initiatives to identify small molecules that modulate cellular proliferation, differentiation, and function and developed potency assays for hematopoietic cell therapy products.